Dr. Gehlhausen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Church Street South, 3rd Floor
Doctor's Building
New Haven, CT 06519
Summary
- Dr. Jeffrey Gehlhausen is a dermatologist based in New Haven, CT, who graduated from Indiana University School of Medicine in 2017. He has expertise in complex autoimmune diseases like dermatomyositis, lupus erythematosus, and vasculitis. Dr. Gehlhausen has published several articles, including research on anti-PM/Scl manifestations, lupus erythematosus, VEXAS Syndrome, broad-spectrum antiviral immunity, and cognitive bias in patient encounters. His work has appeared in journals such as the Journal of the American Academy of Dermatology, Clinics in Dermatology, Journal of Cutaneous Pathology, and the Proceedings of the National Academy of Sciences of the United States of America.
Education & Training
Indiana University School of MedicineClass of 2017
Certifications & Licensure
CT State Medical License 2021 - 2025
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- The readability of online patient education materials for cutaneous autoimmune connective tissue diseases.Sabrina Saeed, Jeff R Gehlhausen, Fotios Koumpouras, Sarika Ramachandran
Clinical Rheumatology. 2025-02-04 - VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the Diagnosis.Christine J Ko, Ian Odell, Jeffrey R Gehlhausen, Jonathan Leventhal, Jennifer M McNiff
Journal of Cutaneous Pathology. 2025-02-01 - Cognitive bias in the patient encounter: Part I. Background and significance.Christine J Ko, Jeffrey R Gehlhausen, Jeffrey M Cohen, Pat Croskerry
Journal of the American Academy of Dermatology. 2025-02-01
Journal Articles
- A Proteasome-Resistant Fragment of NIK Mediates Oncogenic NF-κB Signaling in SchwannomasGeorge Sandusky, Jeffrey R Gehlhausen, Charles W Yates, Steven D Rhodes, Grzegorz Nalepa, Eric Hawley, Jacquelyn D Lajiness, Benjamin Mark Wahle, Human Molecular Genetics
Press Mentions
Dermatomyositis Cancer Screening Guidelines Get Real-World ValidationOctober 3rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
